It’s nice to have more tools in the toolbox so that we’re not trying to fit a square peg in a round hole,” one expert says.
SIRONA tested the sirolimus DCB against seven commercially available paclitaxel DCBs. The study randomized 482 patients (mean ...
Underdiagnosis and undertreatment likely drive the profound effects observed in certain populations, says Juan Granada.
At 6 months, the win ratio favored the device over optimal medical therapy, in large part driven by improved quality of life.
The IRIS-MAIN registry results did show some differences in nonfatal outcomes like stroke, MI, and revascularization.
The postapproval study makes the case that Symplicity Spyral reduces BP across a wide swath of real-world populations.
Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...
Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...
Angiography-Derived FFR vs. Usual Care for Lesion Selection and Optimization in All-Comers PCI: Final Results of the PIONEER IV Randomized Trial Receive the the latest news, research, and ...
Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...
TCT 2238: When Clot-in-Transit Wasn't: ICE-Guided Dual-Platform Aspiration of Pacemaker Lead–Associated Right Atrial Thrombus and in Intermediate-High-Risk Pulmonary Embolism Receive the the latest ...
Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results